Abortion

NEW YORK, August 22 (Praxis Press). Studies have disagreed about the mental health risks associated with elective abortion, but few studies have followed women for long periods of time after abortion or have differentiated between negative emotions and clinically significant psychological distress. Major and colleagues prospectively evaluated emotions, attitudes, and mental health status in 442 women undergoing elective, first-trimester abortion. Two years after the abortion, the majority of wom


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, August 22 (Praxis Press). Studies have disagreed about the mental health risks associated with elective abortion, but few studies have followed women for long periods of time after abortion or have differentiated between negative emotions and clinically significant psychological distress. Major and colleagues prospectively evaluated emotions, attitudes, and mental health status in 442 women undergoing elective, first-trimester abortion. Two years after the abortion, the majority of women were satisfied with their decision (72%), said they would definitely or probably make the same decision again (69%), and felt that the abortion had yielded more good than harm (72%). Eighty percent of women were not depressed at the 2-year time point, but 1% had symptoms of posttraumatic stress disorder. Although depression present before the abortion lessened after the abortion, decision satisfaction and relief decreased and negative emotions increased over time. Women who had a history of depression before pregnancy were ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo